{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:45:09Z","timestamp":1790509509681,"version":"4.1.0"},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Bipolar disorder (BD) mania is a psychiatric disorder with multifaceted symptoms. Development of targeted treatments for BD mania may benefit from animal models that mimic multiple symptoms, as opposed to hyperactivity alone. Using the reverse-translated multivariate exploratory paradigm, the behavioural pattern monitor (BPM), we reported that patients with BD mania exhibit hyperactivity as well as increased specific exploration and more linear movements through space. This abnormal profile is also observed in mice with reduced function of the dopamine transporter (DAT) through either constitutive genetic [knockdown (KD)] or acute pharmacological (GBR12909) means. Here, we assessed the pharmacological predictive validity of these models by administering the BD-treatment valproic acid (VPA) for 28 d. After 1.5% VPA- or regular-chow treatment for 28 d, C57BL\/6J mice received GBR12909 (9 mg\/kg) or saline and were tested in the BPM. Similarly, DAT KD and wild type (WT) littermates were treated with VPA-chow and tested in the BPM. GBR12909-treated and DAT KD mice on regular chow were hyperactive, exhibited increased specific exploration and moved in straighter patterns compared to saline-treated and WT mice respectively. Chronic 1.5% VPA-chow treatment resulted in therapeutic concentrations of VPA and ameliorated hyperactivity in both models, while specific exploration and behavioural organization remained unaffected. Hence, the mania-like profile of mice with reduced functional DAT was partially attenuated by chronic VPA treatment, consistent with the incomplete symptomatic effect of VPA treatment in BD patients. Both DAT models may help to identify therapeutics that impact the full spectrum of BD mania.<\/jats:p>","DOI":"10.1017\/s1461145712001198","type":"journal-article","created":{"date-parts":[[2012,11,20]],"date-time":"2012-11-20T13:52:02Z","timestamp":1353419522000},"page":"1021-1031","source":"Crossref","is-referenced-by-count":45,"title":["Chronic valproate attenuates some, but not all, facets of mania-like behaviour in mice"],"prefix":"10.1093","volume":"16","author":[{"given":"Jordy","family":"van Enkhuizen","sequence":"first","affiliation":[{"name":"Department of Psychiatry, University of California San Diego, CA, USA"},{"name":"Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Geyer","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of California San Diego, CA, USA"},{"name":"Research Service, VA San Diego Healthcare System, San Diego, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaas","family":"Kooistra","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of California San Diego, CA, USA"},{"name":"Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared W.","family":"Young","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of California San Diego, CA, USA"},{"name":"Research Service, VA San Diego Healthcare System, San Diego, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,6,1]]},"reference":[{"key":"2019101113393572100_ref1","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/j.1399-5618.2011.00936.x","article-title":"Striatal dopamine transporter availability in unmedicated bipolar disorder","volume":"13","author":"Anand","year":"2011","journal-title":"Bipolar Disord"},{"key":"2019101113393572100_ref2","volume-title":"Diagnostic and Statistical Manual of Mental Disorders.","author":"APA","year":"1994"},{"key":"2019101113393572100_ref3","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1001\/jama.1994.03510360044034","article-title":"Efficacy of divalproex vs. lithium and placebo in the treatment of mania. The Depakote Mania Study Group","volume":"271","author":"Bowden","year":"1994","journal-title":"J Am Med Assoc"},{"key":"2019101113393572100_ref4","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1038\/npp.2011.128","article-title":"Combined treatment with the mood stabilizers lithium and valproate produces multiple beneficial effects in transgenic mouse models of Huntington's disease","volume":"36","author":"Chiu","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"2019101113393572100_ref5","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/S0140-6736(11)60873-8","article-title":"Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis","volume":"378","author":"Cipriani","year":"2011","journal-title":"Lancet"},{"key":"2019101113393572100_ref6","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.ejphar.2006.02.016","article-title":"Chronic valproate fails to prevent imipramine-induced behavioural sensitization to the dopamine D2-like receptor agonist quinpirole","volume":"535","author":"d'Aquila","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"2019101113393572100_ref7","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.bbr.2009.09.040","article-title":"Antimanic efficacy of retigabine in a proposed mouse model of bipolar disorder","volume":"207","author":"Dencker","year":"2010","journal-title":"Behav Brain Res"},{"key":"2019101113393572100_ref8","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.bbr.2011.07.032","article-title":"The amphetamine-chlordiazepoxide mixture, a pharmacological screen for mood stabilizers, does not enhance amphetamine-induced disruption of prepulse inhibition","volume":"225","author":"Douma","year":"2011","journal-title":"Behav Brain Res"},{"key":"2019101113393572100_ref9","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1523\/JNEUROSCI.3080-07.2008","article-title":"The role of hippocampal GluR1 and GluR2 receptors in manic-like behavior","volume":"28","author":"Du","year":"2008","journal-title":"J Neurosc"},{"key":"2019101113393572100_ref10","doi-asserted-by":"crossref","first-page":"7311","DOI":"10.1523\/JNEUROSCI.23-19-07311.2003","article-title":"The role of the extracellular signal-regulated kinase signaling pathway in mood modulation","volume":"23","author":"Einat","year":"2003","journal-title":"J Neurosci"},{"key":"2019101113393572100_ref11","first-page":"10","article-title":"Strain-specific battery of tests for domains of mania: effects of valproate, lithium and imipramine","volume":"1","author":"Flaisher-Grinberg","year":"2010","journal-title":"Front Psychiatry"},{"key":"2019101113393572100_ref12","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/0091-3057(86)90266-2","article-title":"Multivariate assessment of locomotor behavior: pharmacological and behavioral analyses","volume":"25","author":"Geyer","year":"1986","journal-title":"Pharmacol Biochem Behav"},{"key":"2019101113393572100_ref13","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.neubiorev.2007.05.007","article-title":"Animal models of bipolar disorder and mood stabilizer efficacy: a critical need for improvement","volume":"31","author":"Gould","year":"2007","journal-title":"Neurosci Biobehav Rev"},{"key":"2019101113393572100_ref14","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/sj.mp.4001764","article-title":"Identification of additional variants within the human dopamine transporter gene provides further evidence for an association with bipolar disorder in two independent samples","volume":"11","author":"Greenwood","year":"2006","journal-title":"Mol Psychiatry"},{"key":"2019101113393572100_ref15","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1080\/15622970902823202","article-title":"The world federation of societies of biological psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania","volume":"10","author":"Grunze","year":"2009","journal-title":"World J Biol Psychiatry"},{"key":"2019101113393572100_ref16","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.neuropharm.2010.10.021","article-title":"Epigenetic GABAergic targets in schizophrenia and bipolar disorder","volume":"60","author":"Guidotti","year":"2011","journal-title":"Neuropharmacology"},{"key":"2019101113393572100_ref17","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1177\/0269881108089840","article-title":"Models of mania and antimanic drug actions: progressing the endophenotype approach","volume":"23","author":"Harrison-Read","year":"2009","journal-title":"J Psychopharmacol"},{"key":"2019101113393572100_ref18","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s00213-011-2170-2","article-title":"Effect of methamphetamine dependence on inhibitory deficits in a novel human open-field paradigm","volume":"215","author":"Henry","year":"2011","journal-title":"Psychopharmacology"},{"key":"2019101113393572100_ref19","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ejphar.2007.10.050","article-title":"Chronic valproate normalizes behavior in mice overexpressing calcineurin","volume":"580","author":"Herzog","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"2019101113393572100_ref20","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1038\/sj.mp.4001730","article-title":"A dopamine transporter mutation associated with bipolar affective disorder causes inhibition of transporter cell surface expression","volume":"10","author":"Horschitz","year":"2005","journal-title":"Mol Psychiatry"},{"key":"2019101113393572100_ref21","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1017\/S1461145710001495","article-title":"Evidence for antimanic efficacy of glycogen synthase kinase-3 (GSK3) inhibitors in a strain-specific model of acute mania","volume":"14","author":"Kalinichev","year":"2011","journal-title":"Int J Neuropsychopharmacol"},{"key":"2019101113393572100_ref22","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.neulet.2007.12.005","article-title":"Chronic microinjection of valproic acid into the nucleus accumbens attenuates amphetamine-induced locomotor activity","volume":"432","author":"Kim","year":"2008","journal-title":"Neurosci Lett"},{"key":"2019101113393572100_ref23","doi-asserted-by":"publisher","first-page":"8328","DOI":"10.1021\/ja068969w","article-title":"Structure-based design leads to the identification of lithium mimetics that block mania-like effects in rodents. possible new GSK-3beta therapies for bipolar disorders","volume":"129","author":"Kozikowski","year":"2007","journal-title":"J Am Chem Soc"},{"key":"2019101113393572100_ref24","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/ajmg.b.30707","article-title":"Phenomic, convergent functional genomic, and biomarker studies in a stress-reactive genetic animal model of bipolar disorder and co-morbid alcoholism","volume":"147B","author":"Le-Niculescu","year":"2008","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"2019101113393572100_ref25","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.bbr.2010.05.027","article-title":"Inhibitory control and response latency differences between C57BL\/6J and DBA\/2J mice in a Go\/No-Go and 5-choice serial reaction time task and strain-specific responsivity to amphetamine","volume":"214","author":"Loos","year":"2010","journal-title":"Behav Brain Res"},{"key":"2019101113393572100_ref26","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1001\/archgenpsychiatry.2011.12","article-title":"Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative","volume":"68","author":"Merikangas","year":"2011","journal-title":"Arch Gen Psychiatry"},{"key":"2019101113393572100_ref27","first-page":"e24185","article-title":"Repeated assessment of exploration and novelty seeking in the human behavioral pattern monitor in bipolar disorder patients and healthy individuals","volume":"6","author":"Minassian","year":"2011","journal-title":"Public Libr Sci One"},{"key":"2019101113393572100_ref28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0006-8993(99)01137-3","article-title":"Behavioral organization is independent of locomotor activity in 129 and C57 mouse strains","volume":"835","author":"Paulus","year":"1999","journal-title":"Brain Res"},{"key":"2019101113393572100_ref29","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/BF02244547","article-title":"A temporal and spatial scaling hypothesis for the behavioral effects of psychostimulants","volume":"104","author":"Paulus","year":"1991","journal-title":"Psychopharmacology (Berlin)"},{"key":"2019101113393572100_ref30","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/S0163-1047(87)90619-4","article-title":"Genetic factors and the measurement of exploratory activity","volume":"48","author":"Peeler","year":"1987","journal-title":"Behav Neural Biol"},{"key":"2019101113393572100_ref31","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1001\/archgenpsychiatry.2009.58","article-title":"A reverse-translational study of dysfunctional exploration in psychiatric disorders: from mice to men","volume":"66","author":"Perry","year":"2009","journal-title":"Arch Gen Psychiatry"},{"key":"2019101113393572100_ref32","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1038\/npp.2011.45","article-title":"Dopamine transporter gene variant affecting expression in human brain is associated with bipolar disorder","volume":"36","author":"Pinsonneault","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"2019101113393572100_ref33","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/S0006-3223(02)01489-0","article-title":"Valproate attenuates hyperactive and perseverative behaviors in mutant mice with a dysregulated dopamine system","volume":"53","author":"Ralph-Williams","year":"2003","journal-title":"Biol Psychiatry"},{"key":"2019101113393572100_ref34","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1016\/j.neuropharm.2011.07.025","article-title":"Chronic valproate treatment blocks D(2)-like receptor-mediated brain signaling via arachidonic acid in rats","volume":"61","author":"Ramadan","year":"2011","journal-title":"Neuropharmacology"},{"key":"2019101113393572100_ref35","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.brainresrev.2009.06.003","article-title":"Bipolar disorder and mechanisms of action of mood stabilizers","volume":"61","author":"Rapoport","year":"2009","journal-title":"Brain Res Rev"},{"key":"2019101113393572100_ref36","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1038\/sj.npp.1301161","article-title":"Differential contributions of dopamine D1, D2, and D3 receptors to MDMA-induced effects on locomotor behavior patterns in mice","volume":"31","author":"Risbrough","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"2019101113393572100_ref37","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s007020200035","article-title":"Preliminary evaluation of oral anticonvulsant treatment in the quinpirole model of bipolar disorder","volume":"109","author":"Shaldubina","year":"2002","journal-title":"J Neural Transm"},{"key":"2019101113393572100_ref38","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.neuroscience.2011.09.056","article-title":"The effects of neuropsychiatric drugs on glycogen synthase kinase-3 signaling","volume":"199","author":"Sutton","year":"2011","journal-title":"Neuroscience"},{"key":"2019101113393572100_ref39","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.beth.2008.04.003","article-title":"Life events and social rhythms in bipolar spectrum disorders: a prospective study","volume":"40","author":"Sylvia","year":"2009","journal-title":"Behav Ther"},{"key":"2019101113393572100_ref40","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-012-2854-2","article-title":"Differential effects of dopamine transporter inhibitors in the rodent Iowa Gambling Task: relevance to mania","author":"van Enkhuizen","year":"2012","journal-title":"Psychopharmacology"},{"key":"2019101113393572100_ref41","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1111\/j.1460-9568.2007.05460.x","article-title":"Valproate robustly increases Sp transcription factor-mediated expression of the dopamine transporter gene within dopamine cells","volume":"25","author":"Wang","year":"2007","journal-title":"Eur J Neurosci"},{"key":"2019101113393572100_ref42","first-page":"37","article-title":"Frequency of stimulant treatment and of stimulant-associated mania\/hypomania in bipolar disorder patients","volume":"41","author":"Wingo","year":"2008","journal-title":"Psychopharmacol Bull"},{"key":"2019101113393572100_ref43","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/j.1399-5618.2010.00830.x","article-title":"The international society for bipolar disorders-battery for assessment of neurocognition (ISBD-BANC)","volume":"12","author":"Yatham","year":"2010","journal-title":"Bipolar Disord"},{"key":"2019101113393572100_ref44","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.biopsych.2009.12.015","article-title":"Action of modafinil\u2013increased motivation via the dopamine transporter inhibition and D1 receptors?","volume":"67","author":"Young","year":"2010","journal-title":"Biol Psychiatry"},{"key":"2019101113393572100_ref45","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00213-009-1744-8","article-title":"GBR 12909 administration as a mouse model of bipolar disorder mania: mimicking quantitative assessment of manic behavior","volume":"208","author":"Young","year":"2010","journal-title":"Psychopharmacology"},{"key":"2019101113393572100_ref46","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.pbb.2010.03.014","article-title":"The mania-like exploratory profile in genetic dopamine transporter mouse models is diminished in a familiar environment and reinstated by subthreshold psychostimulant administration","volume":"96","author":"Young","year":"2010","journal-title":"Pharmacol Biochem Behav"},{"key":"2019101113393572100_ref47","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1111\/j.1476-5381.2011.01318.x","article-title":"Predictive animal models of mania, hits, misses, and future directions","volume":"164","author":"Young","year":"2011","journal-title":"Br J Pharmacol"},{"key":"2019101113393572100_ref48","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1038\/npp.2011.23","article-title":"Dopamine receptor mediation of the exploratory\/hyperactivity effects of modafinil","volume":"36","author":"Young","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"2019101113393572100_ref49","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.neubiorev.2007.05.009","article-title":"A reverse-translational approach to bipolar disorder: rodent and human studies in the Behavioral Pattern Monitor","volume":"31","author":"Young","year":"2007","journal-title":"Neurosci Biobehav Rev"},{"key":"2019101113393572100_ref50","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1177\/0269881111400646","article-title":"Increased risk-taking behavior in dopamine transporter knockdown mice: further support for a mouse model of mania","volume":"25","author":"Young","year":"2011","journal-title":"J Psychopharmacol"},{"key":"2019101113393572100_ref51","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1073\/pnas.98.4.1982","article-title":"Hyperactivity and impaired response habituation in hyperdopaminergic mice","volume":"98","author":"Zhuang","year":"2001","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["International Journal of Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ijnp\/article-pdf\/16\/5\/1021\/30135093\/16-5-1021.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ijnp\/article-pdf\/16\/5\/1021\/30135093\/16-5-1021.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T20:42:58Z","timestamp":1570826578000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ijnp\/article\/16\/5\/1021\/713736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,1]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,6,1]]}},"URL":"https:\/\/doi.org\/10.1017\/s1461145712001198","relation":{},"ISSN":["1469-5111","1461-1457"],"issn-type":[{"value":"1469-5111","type":"electronic"},{"value":"1461-1457","type":"print"}],"subject":[],"published-other":{"date-parts":[[2013,6]]},"published":{"date-parts":[[2013,6,1]]}}}